Articles tagged with Ophthalmology
Researchers developed a portable sensor, OcuCheck, that uses graphene and ascorbate oxidase to detect vitamin C levels in ocular fluids. The device can rapidly determine the extent of eye injuries in various settings, including rural areas with limited access to ophthalmologists.
A new study published in the Journal of AAPOS found that children with amblyopia read more slowly than those with normal vision or strabismus. Amblyopic children exhibited about 35% more forward eye movements during reading, contributing to their slower reading speed.
A new study presents a regenerative agent, Cacicol, that speeds up the healing of corneal tissue after surgery, reducing recovery time by up to 70% and minimizing complications. The treatment also alleviates eye pain, burning, and light sensitivity.
The American Academy of Ophthalmology's IRIS Registry has revealed new information on rare complications following common eye procedures. Analysis shows no significant difference in endophthalmitis rates among three anti-VEGF treatments, but slightly higher rates in eyes with combined cataract surgery and anterior vitrectomy.
Researchers found that low-dose atropine eye drops significantly slowed myopia progression in children, with a 50% reduction compared to untreated children. The medication is safe for use in children age 6-12 for up to five years and may be an effective treatment in the fight against global nearsightedness.
Researchers have developed programmable electronic glasses that help improve vision in children with lazy eye as effectively as traditional treatment using eye patches. The 'digital patch' is a new effective treatment for lazy eye in half a century, offering an alternative to traditional methods.
Research identifies falls as the leading cause of eye injuries, accounting for over 8,425 hospitalizations, with serious ocular trauma injuries being expensive and preventable. The median cost of treating eye injuries increased by 62%, from $12,430 to $20,116, between 2002 and 2011.
Researchers discovered that anti-PlGF antibody treatments, such as aflibercept, may slow the progression of dry age-related macular degeneration. The study found that PlGF actually worsened retinal damage in mice, but an anti-PlGF treatment provided protection against light-induced degeneration.
A home monitoring device for AMD showed promise in patients who completed a qualification test, allowing them to track progression at home. Younger participants were more likely to qualify and successfully use the device.
Researchers used popular animated films to improve visual acuity in young children with amblyopia through dichoptic therapy. Visual acuity improved by 1-4 lines over six sessions of movie viewing, outperforming patching treatments.
Researchers found that blind areas in central vision can delay drivers' ability to detect pedestrians, even when using peripheral vision. The study suggests that any binocular central field loss might impact a driver's reaction time.
Researchers found that advanced diabetic eye disease remains low among children living with diabetes, regardless of disease duration. They recommend delaying annual screenings until age 15 or 5 years after diagnosis for most children with type 1 diabetes.
A new Penn study analyzing insurance claims data suggests that repackaged Avastin injections do not carry a higher risk of endophthalmitis than commercially available Lucentis. This finding contradicts the FDA's planned restriction on Avastin's ophthalmic use and may inadvertently increase infection risk for patients.
Researchers reconstructed an ancient virus to deliver gene therapies, targeting liver, muscle, and retina. The discovery could lead to safer and more potent treatments for various diseases.
Researchers at Mass Eye and Ear discovered that the alternative complement pathway exacerbates photoreceptor cell death after injury, but blocking it can protect photoreceptors. Inhibition of this pathway offers a new therapeutic target to prevent initial photoreceptor loss.
A three-year clinical trial results show that the Argus II device improves visual function and quality of life for people with retinitis pigmentosa by up to 89%. The study found no device failures after three years and no negative impact on patients.
A randomized trial found that combining personalized risk assessments and diabetes education at ophthalmologic visits did not improve HbA1c levels in patients with type 1 or 2 diabetes. The study suggests that long-term optimization of glycemic control requires more extensive interventional paradigms.
A new study reveals a direct correlation between seasonal allergens and dry eye cases, with both conditions peaking in April. Dry eye can significantly impact quality of life, affecting millions in the US annually.
A new virtual reality testing environment provides a more realistic assessment of balance control in glaucoma patients. The study found that patients with glaucoma made balance adjustments 30-40% more pronounced than healthy subjects, highlighting the need for preventative measures.
Researchers found that severing corneal nerves during the first transplantation procedure releases high levels of Substance P, disabling T regulatory cells needed for acceptance of subsequent corneal transplants. This results in rejection of more than 90% of second corneal transplants in mice.
Researchers found routine preoperative testing for cataract surgery is still done in 53% of patients, despite being unnecessary. Testing varies widely among ophthalmologists and seems to be driven more by provider behavior than patient characteristics.
Researchers developed a wearable collision warning device to help patients with peripheral vision loss avoid collisions. The device gave auditory warnings only when users approached obstacles, reducing collisions by 37% and improving mobility performance.
A study published in Investigative Ophthalmology & Visual Science reveals that cells multiplying on the eye's lens surface push neighboring cells towards the equator, mirroring a carnival game's coin movement. This insight may help scientists understand how the eye maintains its shape and develop cataracts.
A new study led by USC Eye Institute finds that ranibizumab may help reduce cases of blindness by 75 percent among Hispanic and non-Hispanic whites with diabetic macular edema. The treatment could potentially save the sight of thousands of working-age individuals suffering from diabetic eye disease.
A recent study of 20,000 Chinese children found that lower-income students had nearly twice the prevalence of nearsightedness as their middle-class counterparts. Using blackboards in classrooms may have played a protective role against myopia in poorer areas, but this was not statistically significant when adjusted for other factors.
A new gene, hexokinase 1 (HK1), has been linked to retinitis pigmentosa, an incurable eye disorder affecting millions worldwide. The discovery brings the total number of genes associated with this disease to over 60 and offers potential targets for drug treatments and gene therapy.
A study by the American Academy of Ophthalmology found that 7 out of 11 popular eye vitamins do not match scientific evidence, with some products containing lower doses of essential ingredients. The study highlights the importance of ophthalmologists educating patients on the proper use of nutritional supplements for AMD treatment.
Researchers have developed a fast and inexpensive way to create custom facial prostheses using 3D printing technology, providing an affordable alternative to traditional prosthetics. The novel process can produce prosthetics in hours at a fraction of the cost of conventional ones, which can range from $10,000 to $15,000.
A large retrospective study found that nearly 60% of patients with both uveitis and multiple sclerosis (MS) are diagnosed with each condition within a five-year span. The study also revealed that MS is more likely to be diagnosed before or after uveitis, not simultaneously.
A new device called a punctum plug has been shown to be effective at reducing pain and inflammation following cataract surgery. The implant delivers the correct amount of postoperative medication, potentially solving issues of poor patient compliance with eye drops.
A new smartphone-based tool has been developed to monitor diabetic eye disease, offering comparable results to traditional equipment. The tool, called D-Eye, uses a small optical adapter that attaches magnetically to an iPhone and enables ophthalmologists to evaluate the severity of the disease.
Researchers successfully used an iPhone application to image the inside of the eye, including in pediatric and immobile patients. The iExaminer system is a portable, inexpensive tool for fundus photography and videography, offering potential for prompt telemedicine consultations with an ophthalmologist.
A study released by the American Academy of Ophthalmology found that an implantable corneal inlay device improved near vision well enough for 80% of patients to read a newspaper without affecting far distance vision. The device is currently undergoing clinical review in the US and has shown promising results with minimal complications.
A new study reports significant ocular injuries from liquid laundry and dishwasher detergent pods. The bursting pods can cause severe corneal abrasions, bloodshot eyes, and other complications.
Ferrara's discovery of vascular endothelial growth factor (VEGF) led to the development of ranibizumab, a monoclonal antibody drug treating wet macular degeneration and diabetic eye disease. This achievement has significantly improved vision for patients affected by these conditions.
Researchers found a link between residential geography, time spent in the sun, and XFS risk. Wearing sunglasses for summer hours reduced odds of XFS by 2%.
A new study from USC Eye Institute reveals that Native American ancestry is a significant risk factor for vision-threatening diabetic retinopathy among Latinos with Type 2 diabetes. The research found individuals with more than 50% Native American ancestry had an 87% higher chance of developing severe diabetic retinopathy.
A new DNA test can identify the exact genetic cause of congenital cataracts in 75% of cases, allowing for earlier treatment and genetic counseling. The targeted next-generation sequencing test has been shown to be effective in diagnosing rare diseases associated with childhood blindness.
The study highlights the need for improved screening and access to treatments for diabetic macular edema, a leading cause of blindness in diabetic patients. African Americans have a higher burden of diabetes-related vision loss due to problems with access to care.
Experts criticize UK dyslexia charities for promoting the use of colored overlays and lenses without discussing the conflicting evidence base. This can lead to individuals spending large amounts of money on unproven products or expecting NHS support. Charities should adopt an evidence-based approach to educate the public on managing re...
Researchers found that dietary iodine intake was inversely related to central foveal swelling in RP patients with CME. This finding suggests that an iodine supplement could help limit or reduce retinal swelling in these patients.
A NIH-funded study found that telemedicine screening for ROP in premature infants can correctly identify cases with 90% accuracy. The approach, which involves sending photos of baby eyes to a distant image reading center, could help ease strain on hospitals and improve care for underserved areas.
A new multicenter study validated a telemedicine approach to screening for retinopathy of prematurity (ROP), a leading cause of treatable blindness in preterm babies. Trained non-physician evaluators accurately identified high-risk eyes, suggesting this method could help prevent thousands of kids from going blind.
Two Harvard Medical School faculty members, Patricia D'Amore and Joan Miller, have been recognized with the 2015 Proctor Medal and Mildred Weisenfeld Award for Excellence in Ophthalmology, respectively. Their groundbreaking research on vascular growth and development has led to significant advancements in anti-angiogenic therapies, imp...
Researchers found that a 'treat and extend' strategy can reduce the average number of visits and injections from 12 to 8.3 times per year for patients with age-related macular degeneration. This approach could lower the financial burdens on patients, families, and government.
A study of over 400 Vietnamese patients found a significant decrease in falls after cataract surgery on one eye, with risks reduced by 78% the year following treatment. Researchers monitored patients before and after surgery to track the impact of improved vision on daily life.
Researchers developed a thermoresponsive adhesive that warms up and seals wounds, then reverts to its non-adhesive form when cooled. The technology could prevent retinal detachment and vision loss in military-related eye injuries.
Researchers have developed a new gel-based eye fluid called Healaflow that stabilizes the eye during healing after retinal detachment surgery. This new product does not appear to inflict additional damage on the retina, setting it apart from other alternatives.
Researchers have recreated the 3D architecture of the cornea to facilitate the transplant of healthy corneal stem cells. This innovation restores sight by replacing damaged cell layers with functional ones.
Researchers developed methods to convert stem cells into eye cells that could be used to replace damaged tissue in patients with impaired vision. The studies involved converting cells into nerve cells or introducing stem cells to a growth factor, resulting in tissue resembling the developing eye.
Researchers have developed gene therapies to prevent and treat blinding diseases, including choroideremia and retinitis pigmentosa. These treatments involve replacing missing genes in the cells at the back of the eye, resulting in improved vision for some patients.
A case report documents a 27-week-old premature infant's cardiopulmonary arrest after receiving Cyclomydril eyedrops during retinopathy of prematurity screening. Pediatric ophthalmologists should be equipped to handle such emergencies, as the eyedrops can cause serious side effects due to systemic absorption.
Researchers found that drivers with hemianopia had lower detection rates for pedestrians on the side of their field loss due to inadequate scanning patterns. These individuals often failed to scan the entire intersection or scanned too little, increasing the risk of accidents.
Researchers at Stanford University School of Medicine have developed two inexpensive adapters that allow smartphones to capture high-quality images of the front and back of the eye. The adapters make it easy for anyone with minimal training to take a picture of the eye and share it securely with other health practitioners or store it i...
Researchers have designed a system-on-chip that could enable fully implanted cochlear implants, restoring hearing in individuals with profound loss. The internal unit would be wirelessly rechargeable and require lower power sound processing.
Massachusetts Eye and Ear Hospital has awarded Christina Marsica Grassi a $30,000 fellowship to investigate sterile vitritis in patients with artificial corneal implants. The research project aims to improve understanding of immune responses to prosthetic devices and develop better treatments for this condition.
A study published in Ophthalmology found that open globe injuries increase the risk of retinal detachment, particularly among older patients with poorer visual acuity. Researchers developed a new scoring system to predict which patients are at higher risk, which may help prevent or identify and repair retinal detachment more quickly.
Researchers found that adding a corticosteroid to standard treatment significantly improves both short- and long-term visual acuity in patients with nonarteritic anterior ischemic optic neuropathy (NAION). The study showed that patients treated with the combination therapy had better long-term vision compared to those only treated with...
A new NIH-funded study found that cornea donation from donors aged 34-71 maintains high success rates after 10 years. While older donors may experience slightly lower success rates, the majority remain healthy and functional.
A multi-center study showed that peripheral prism glasses significantly outperformed sham devices in helping patients with hemianopia avoid obstacles during everyday walking. After six months, 41% of patients continued to wear the real glasses, reporting improved navigation in various environments.